BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2011
View Archived Issues
Final data disclosed from phase II NKTR-102 trial in metastatic breast cancer
Read More
Spanish university identifies new biomarker of brain abnormalities in schizophrenia
Read More
HPI-1-encapsulating polymeric nanoparticle tested in preclinical models of HCC
Read More
Pfizer reports pivotal data on tofacitinib in rheumatoid arthritis
Read More
New modified ADAM-derived polypeptides disclosed by USC
Read More
Researchers optimize Mer inhibitors for treatment of acute lymphoblastic leukemia
Read More
Preclinical and phase I data presented on insulin sensitizer LIM-0705
Read More
Several trials assess Anacor's boron-based therapies in healthy subjects and psoriasis
Read More
Scientists at BMS prepare novel agents for hepatitis C
Read More
New bradykinin B1 receptor antagonists synthesized
Read More
Researchers at Merck & Co. disclose new AMPK activators
Read More
Novel PLK1 inhibitors claimed by Boehringer Ingelheim Pharma
Read More
Ironwood Pharmaceuticals patents new GC-C agonists
Read More
Transcept Pharmaceuticals plans next resubmission of Intermezzo NDA
Read More
BioAlliance reports preliminary phase I data on AMEP biotherapy
Read More
Single-dose NeoVisc approved for sale in Europe
Read More
Daiichi Sankyo and AstraZeneca launch Nexium capsules in Japan
Read More
Mitsubishi Tanabe and Janssen to market Simponi in Japan
Read More
Cempra Pharmaceuticals reports data from phase II solithromycin trial
Read More
FDA grants new orphan drug status to Revimmune
Read More
FDA grants two fast track designations to QLT's oral synthetic retinoid
Read More
Soligenix reports on recent data safety monitoring board review of orBec study
Read More
Japanese MHLW grants additional approval to CellCept
Read More
Thallion reports on phase II SHIGATEC trial
Read More
Takeda advances TAK-438 into phase III trials in Japan
Read More